Colleen K McIlvennan1, Daniel D Matlock2, Madhav P Narayan3, Carolyn Nowels4, Jocelyn S Thompson5, Anne Cannon6, William J Bradley6, Larry A Allen7. 1. Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA; Colorado Health Outcomes Group, University of Colorado School of Medicine, Aurora, CO, USA. Electronic address: colleen.mcilvennan@ucdenver.edu. 2. Colorado Health Outcomes Group, University of Colorado School of Medicine, Aurora, CO, USA; Division of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA. 3. University of Colorado, Boulder, CO, USA. 4. Division of Internal Medicine, University of Colorado School of Medicine, Aurora, CO, USA. 5. Colorado Health Outcomes Group, University of Colorado School of Medicine, Aurora, CO, USA. 6. Program of Mechanical Circulatory Support, University of Colorado Hospital, Aurora, CO, USA. 7. Division of Cardiology, University of Colorado School of Medicine, Aurora, CO, USA; Colorado Health Outcomes Group, University of Colorado School of Medicine, Aurora, CO, USA.
Abstract
OBJECTIVE: To understand mechanical circulatory support (MCS) coordinators' perspectives related to destination therapy left ventricular assist devices (DT LVAD) decision making. BACKGROUND: MCS coordinators are central to the team that interacts with patients considering DT LVAD, and are well positioned to comment upon the pre-implantation process. METHODS: From August 2012 to January 2013, MCS coordinators were recruited to participate in semi-structured, in-depth interviews. Established qualitative approaches were used to analyze and interpret data. RESULTS: Eighteen MCS coordinators from 18 programs were interviewed. We found diversity in coordinators' roles and high programmatic variability in how DT LVAD decisions are approached. Despite these differences, three themes were consistently recommended: 1) DT LVAD is a major patient-centered decision: "you're your best advocate… this may not be the best choice for you"; 2) this decision benefits from an iterative, multidisciplinary process: "It is not a one-time conversation"; and 3) this process involves a tension between conveying enough detail about the process yet not overwhelming patients: "It's sometimes hard to walk that line to not scare them but not paint a rainbow and butterflies picture." CONCLUSIONS: MCS coordinators endorsed a shared decision-making process that starts early, uses non-biased educational materials, and involves a multidisciplinary team sensitive to the tension between conveying enough detail about the therapy yet not overwhelming patients.
OBJECTIVE: To understand mechanical circulatory support (MCS) coordinators' perspectives related to destination therapy left ventricular assist devices (DT LVAD) decision making. BACKGROUND:MCS coordinators are central to the team that interacts with patients considering DT LVAD, and are well positioned to comment upon the pre-implantation process. METHODS: From August 2012 to January 2013, MCS coordinators were recruited to participate in semi-structured, in-depth interviews. Established qualitative approaches were used to analyze and interpret data. RESULTS: Eighteen MCS coordinators from 18 programs were interviewed. We found diversity in coordinators' roles and high programmatic variability in how DT LVAD decisions are approached. Despite these differences, three themes were consistently recommended: 1) DT LVAD is a major patient-centered decision: "you're your best advocate… this may not be the best choice for you"; 2) this decision benefits from an iterative, multidisciplinary process: "It is not a one-time conversation"; and 3) this process involves a tension between conveying enough detail about the process yet not overwhelming patients: "It's sometimes hard to walk that line to not scare them but not paint a rainbow and butterflies picture." CONCLUSIONS:MCS coordinators endorsed a shared decision-making process that starts early, uses non-biased educational materials, and involves a multidisciplinary team sensitive to the tension between conveying enough detail about the therapy yet not overwhelming patients.
Authors: E A Rose; A C Gelijns; A J Moskowitz; D F Heitjan; L W Stevenson; W Dembitsky; J W Long; D D Ascheim; A R Tierney; R G Levitan; J T Watson; P Meier; N S Ronan; P A Shapiro; R M Lazar; L W Miller; L Gupta; O H Frazier; P Desvigne-Nickens; M C Oz; V L Poirier Journal: N Engl J Med Date: 2001-11-15 Impact factor: 91.245
Authors: Josef Stehlik; Leah B Edwards; Anna Y Kucheryavaya; Christian Benden; Jason D Christie; Fabienne Dobbels; Richard Kirk; Axel O Rahmel; Marshall I Hertz Journal: J Heart Lung Transplant Date: 2011-10 Impact factor: 10.247
Authors: James K Kirklin; David C Naftel; Francis D Pagani; Robert L Kormos; Lynne W Stevenson; Elizabeth D Blume; Marissa A Miller; J T Baldwin; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2014-04-21 Impact factor: 10.247
Authors: Matthew C Iacovetto; Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; William Bradley; Shane J LaRue; Larry A Allen Journal: Circ Cardiovasc Qual Outcomes Date: 2014-10-14
Authors: Keith M Swetz; Monica R Freeman; Omar F AbouEzzeddine; Kari A Carter; Barry A Boilson; Abigale L Ottenberg; Soon J Park; Paul S Mueller Journal: Mayo Clin Proc Date: 2011-06 Impact factor: 7.616
Authors: Mark S Slaughter; Joseph G Rogers; Carmelo A Milano; Stuart D Russell; John V Conte; David Feldman; Benjamin Sun; Antone J Tatooles; Reynolds M Delgado; James W Long; Thomas C Wozniak; Waqas Ghumman; David J Farrar; O Howard Frazier Journal: N Engl J Med Date: 2009-11-17 Impact factor: 91.245
Authors: Aaron G Rizzieri; Joseph L Verheijde; Mohamed Y Rady; Joan L McGregor Journal: Philos Ethics Humanit Med Date: 2008-08-11 Impact factor: 2.464
Authors: Daniel D Matlock; Colleen K McIlvennan; Jocelyn S Thompson; Megan A Morris; Grace Venechuk; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Laura Blue; Erin L Chaussee; Russell E Glasgow; Mary Norine Walsh; Larry A Allen Journal: Med Decis Making Date: 2020-04 Impact factor: 2.583
Authors: Jocelyn S Thompson; Daniel D Matlock; Colleen K McIlvennan; Amy R Jenkins; Larry A Allen Journal: JACC Heart Fail Date: 2015-12 Impact factor: 12.035
Authors: Jocelyn S Thompson; Monica D Fitzgerald; Larry A Allen; Colleen K McIlvennan; Russell E Glasgow; Matthew Wynia; Megan A Morris; John Beilenson; Chris Gherst; Dan D Matlock Journal: Circ Cardiovasc Qual Outcomes Date: 2021-02-03
Authors: Larry A Allen; Colleen K McIlvennan; Jocelyn S Thompson; Shannon M Dunlay; Shane J LaRue; Eldrin F Lewis; Chetan B Patel; Laura Blue; Diane L Fairclough; Erin C Leister; Russell E Glasgow; Joseph C Cleveland; Clifford Phillips; Vicie Baldridge; Mary Norine Walsh; Daniel D Matlock Journal: JAMA Intern Med Date: 2018-04-01 Impact factor: 21.873